|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/155 | (2006.01) |
| A61K 39/245 | (2006.01) | ||
| C12N 15/86 | (2006.01) | ||
| C12N 15/88 | (2006.01) |
| (11) | Number of the document | 4005592 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21204155.2 |
| Date of filing the European patent application | 2011-07-06 | |
| (97) | Date of publication of the European application | 2022-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-12 |
| (46) | Date of publication of the claims translation | 2023-01-10 |
| (30) | Number | Date | Country code |
| 36182810 P | 2010-07-06 | US |
| (72) |
GEALL, Andrew , US
MANDL, Christian , US
O'HAGAN, Derek , US
SINGH, Manmohan , US
|
| (73) |
GlaxoSmithKline Biologicals S.A. ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Viriono tipo tiekimo dalelės, skirtos savaime besireplikuojančioms RNR molekulėms |
| VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 15 | 289.00 EUR |
| 2026-07-06 |